Herantis Pharma Oyj HRPMF
3.51 0.00 0.00%
As of Sep 9, 9:42 AM ET
52-week range unavailable
- Open
- 3.51
- Prev close
- 3.51
- Mkt cap
- 59.47M
- Vol
- 1.10K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 3.51
- High
- 3.51
MAX chart
Chart tools
Chart is warming up
The all-time price history for HRPMF has not been loaded yet. Try again in a moment.
Altman Z-Score
-41.16 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
P/E -14.1×
P/S 0.0×
P/B -281×
P/FCF -10.4×
EV/EBITDA 732×
EV/Sales 0.0×
FCF Yield -9.6%
Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
ROE 2032.5%
ROIC -258.8%
ROA -192.1%
Revenue 0.0%
Operating Income -3355.9%
EPS (diluted) -1572.4%
Free Cash Flow -41.2%
Current Ratio 4.1×
Quick Ratio 4.1×
Debt / Equity -0.1×
Net Debt / EBITDA -6.5×
Interest Coverage -888×
Dividend Yield 0.0%
Payout Ratio 0.0%
Annual · latest fiscal year ends 2024-12-31